Building on the success of MitoXpress® Xtra Oxygen Consumption Assay, Luxcel Biosciences, now a part of Agilent, has created and is rapidly expanding a one-stop-shop of in vitro cell-based assay tests and kits, targeting Cell Metabolism, Drug Safety and Hypoxia / Oxidative Stress for the Life Sciences market. These 96- and 384-well microtitre-based fluorescence assays measure essential cellular metabolic pathways, and are configured for use on standard fluorescence plate readers, providing easy-to-use solutions for basic research, drug discovery and safety toxicology.
Luxcel Biosciences is an award-winning developer of innovative optical fluorescence test solutions, used by scientists and technicians from Universities to global Pharmaceutical Companies, with a proven ability to transform existing specialized tests, into new, high performance, affordable and easy-to-use products.
We are a young and motivated team, with a shared passion for enabling and supporting our customers, to get the best possible results from the use of our products.
Some of the Luxcel Biosciences' team
Representing MetaCell at BSCR 2017
MetaCell Team Meeting at the University of Oxford
Luxcel Demo at Foie Gras Network School 2017
We Love Toxicology! SOT 2017
CEO Richard Fernandes with CEOs of Axiogenesis (now Ncardia) and BMG LABTECH
COO Ian Hayes with Ncardia Team at SPS Berlin 2017
Commercial Director Ian Hayes and Bio-Gene's Zumei Liu at AACR Shanghai
A HISTORY OF INNOVATION
MitoXpress® Xtra - 1st high throughput OCR test, for the measurement of mitochondrial toxicity in the Pharmaceutical industry.
OpTech® - 1st handheld reader for non-invasive measurement of oxygen in the Packaging industry.
GreenLight® - 1st reagent-free system for real-time measurement of microbial contamination in the Food and Beverage industry.
MetaCell a Gold Standard platform, comprising cell assays, disease models and services, with high performance metabolism tests designed for use on laboratory standard instrumentation.